Delivery Order SPE2DB20D9127-SPE2DB25FPRL5
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. The contract, which became effective on August 1, 2025, with an ultimate completion date of August 4, 2025, was issued without set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc. for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its Park Ridge location with an ultimate completion date of September 10, 2025. This delivery order was awarded without a set-aside designation on September...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $55,464.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. The order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and does not utilize a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- The Defense Logistics Agency awarded a $38,628.38 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Trikafta 80-40-60 mg/59.5 mg tablets in packets of 14 units. The award was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and represents a non-set-aside award to the woman-owned small business contractor. Performance will be executed from the contractor's facility in Park Ridge, Illinois. This delivery order falls under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,474.02 on August 5, 2025, for the supply of Trikafta 50-25-37.5 mg/75 mg tablets (84-count units). The contract carries no set-aside designation and is set to be completed by August 6, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain division, a defense-focused federal agency responsible...
- The Defense Logistics Agency awarded a delivery order valued at $93,269.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count unit dosage). This firm fixed-price delivery order was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and does not utilize a set-aside designation. The contract falls under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on August 8, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order carries an ultimate completion date of August 11, 2025, and involves no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award...
- The Defense Logistics Agency awarded a delivery order valued at $36,976.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a discrete pharmaceutical fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA....
- The U.S. Defense Logistics Agency (DLA) awarded a $18,526.83 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order for the drug Trikafta is being fulfilled under a larger single-award indefinite delivery contract (IDC), valued up to $499,999,999, awarded to DMS by the DLA. The IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Trikafta 100-50-75 mg/75 mg packets in quantities of 14. This firm fixed-price delivery order, valued at $37,804.69, was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The award carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPRL5Delivery Order
The Defense Logistics Agency awarded a $18,474.02 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Trikafta 50-25-37.5 mg/75 mg tablets (84-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This delivery order was issued without a set-aside designation and will be performed at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, serves as the prime contractor and is registered in the System for Award Management since 2001. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC enables DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products supporting Department of Defense healthcare facilities worldwide. Trikafta, a prescription medication used in treating cystic fibrosis, represents one of numerous pharmaceutical products the contractor supplies to military health facilities as part of its established role as a critical supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 9/12/25 |